バイオチップの世界市場レポート 2025

バイオチップ市場規模は、今後数年で急成長が見込まれます。2029年には複合年間成長率（CAGR）16.3％で269億4,000万米ドルに成長します。予測期間の成長機会は、ポイントオブケア診断における採用の増加、医薬品開発におけるアプリケーションの拡大、個別化医療に対する需要の高まり、マイクロ流体技術の進歩、研究開発への投資の拡大、バイオテクノロジー企業と学術機関の協力関係の拡大、農業バイオテクノロジーにおける新たな機会の出現などに起因すると考えられます。予測期間における主な動向としては、マイクロ流体技術の進歩、リキッドバイオプシーアプリケーション向けバイオチップの開発重視、複数分析物の同時検出を目的としたマルチプレックスアッセイに対する需要の高まり、データ解析のための人工知能の統合、新規バイオチッププラットフォームの出現などが挙げられます。

バイオチップ市場は、個別化医療の採用が増加していることから成長が見込まれています。個別化医療は、遺伝学やライフスタイルなどの個人の特性に基づいて治療をカスタマイズするもので、効果を最適化し副作用を最小限に抑えることを目的としています。この動向は、より効果的な治療を提供する個別化医療の可能性、ゲノミクスの進歩、疾病の複雑化、規制の後ろ盾によって後押しされています。バイオチップは、人の遺伝子プロファイルに基づいた正確で個別化された治療計画を可能にすることで、個別化医療において重要な役割を果たしています。例えば、2024年2月、FDAは希少疾患に対する16の新規個別化療法を承認しており、個別化医療導入の勢いとバイオチップ市場への影響を浮き彫りにしています。

バイオチップ市場の主要企業は、創薬・市場開拓プロセスを変革するため、臓器オンチップ・プラットフォームなどの最先端技術の開発に注力しています。臓器オンチップ・プラットフォームは、人間の臓器の生理学的特性や機能を小規模で模倣するように設計された高度なマイクロ流体デバイスです。例えば、2024年4月、ボストン・マイクロ・ファブリケーション（BMF）はBMF Biotechnology Inc.を立ち上げ、バイオチップや、試験管内で大規模組織を培養するための臓器オンチップ・プラットフォームに特化しています。この進歩は、人体外での試験・研究プラットフォームを提供することで、医薬品や化粧品開発を加速させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオチップ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオチップ市場：成長率分析
• 世界のバイオチップ市場の実績：規模と成長, 2019-2024
• 世界のバイオチップ市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオチップ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオチップ市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デオキシリボ核酸（DNA）チップ
• プロテインチップス
• ラボオンチップ
• 組織アレイ
• 細胞アレイ
• 世界のバイオチップ市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロアレイ
• マイクロ流体工学
• 世界のバイオチップ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品の発見と開発
• 農業
• ゲノミクス
• 病気の診断
• プロテオミクス
• その他の用途
• 世界のバイオチップ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジーおよび製薬会社
• 学術研究機関
• 病院と診断センター
• その他のエンドユーザー
• 世界のバイオチップ市場デオキシリボ核酸（DNA）チップの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子発現チップ
• SNP（一塩基多型）チップ
• DNAマイクロアレイ
• 世界のバイオチップ市場プロテインチップの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体アレイ
• タンパク質マイクロアレイ
• ペプチドアレイ
• 世界のバイオチップ市場ラボオンチップのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロ流体デバイス
• バイオセンサー
• 世界のバイオチップ市場組織アレイのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍組織アレイ
• 正常組織アレイ
• 世界のバイオチップ市場、細胞アレイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• セルベースのバイオチップ
• 細胞シグナル伝達アレイ

第7章 地域別・国別分析

• 世界のバイオチップ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオチップ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオチップ市場：競合情勢
• バイオチップ市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Tecan Group Ltd.
• Cepheid Inc.
• Randox Laboratories Ltd.
• Takara Bio Inc.
• Oxford Nanopore Technologies plc
• Luminex Corporation
• Fluidigm Corporation
• Micronit Microtechnologies B.V.
• Sphere Fluidics Limited
• Sengenics
• Arrayit Corporation
• CustomArray Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオチップ市場2029：新たな機会を提供する国
• バイオチップ市場2029：新たな機会を提供するセグメント
• バイオチップ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $12.62 billion in 2024 to $14.72 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to increased demand for personalized medicine, high prevalence of chronic diseases, technological innovations, expanded applications in drug discovery, growth in investments in research and development, and supportive regulatory frameworks.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $26.94 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to increasing adoption in point-of-care diagnostics, expanding applications in drug development, rising demand for personalized medicine, advancements in microfluidics technology, growing investments in research and development, expanding collaborations between biotechnology companies and academic institutions, and emerging opportunities in agricultural biotechnology. Major trends in the forecast period include advancements in microfluidics technology, emphasis on developing biochips for liquid biopsy applications, rising demand for multiplexed assays for simultaneous detection of multiple analytes, integration of artificial intelligence for data analysis, and the emergence of novel biochip platforms.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Deoxyribonucleic Acid (DNA) Chips; Protein Chips; Lab-On-Chip; Tissue Arrays; Cell Arrays
• 2) By Technology: Microarrays; Microfluidics
• 3) By Application: Drug Discovery And Development; Agriculture; Genomics; Disease Diagnostics; Proteomics; Other Applications
• 4) By End-User: Biotechnology And Pharmaceutical Companies; Academic And Research Institutes; Hospitals And Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips; Snp (Single Nucleotide Polymorphism) Chips; Dna Microarrays
• 2) By Protein Chips: Antibody Arrays; Protein Microarrays; Peptide Arrays
• 3) By Lab-On-Chip: Microfluidic Devices; Biosensors
• 4) By Tissue Arrays: Tumor Tissue Arrays; Normal Tissue Arrays
• 5) By Cell Arrays: Cell-Based Biochips; Cell Signaling Arrays
• Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd; Zoetis Inc.; Agilent Technologies Inc.; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biochips Market Characteristics

3. Biochips Market Trends And Strategies

4. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biochips Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biochips PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biochips Market Growth Rate Analysis
• 5.4. Global Biochips Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biochips Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biochips Total Addressable Market (TAM)

6. Biochips Market Segmentation

• 6.1. Global Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid (DNA) Chips
• Protein Chips
• Lab-On-Chip
• Tissue Arrays
• Cell Arrays
• 6.2. Global Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microarrays
• Microfluidics
• 6.3. Global Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Development
• Agriculture
• Genomics
• Disease Diagnostics
• Proteomics
• Other Applications
• 6.4. Global Biochips Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology And Pharmaceutical Companies
• Academic And Research Institutes
• Hospitals And Diagnostic Centers
• Other End-Users
• 6.5. Global Biochips Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Chips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Expression Chips
• SNP (Single Nucleotide Polymorphism) Chips
• DNA Microarrays
• 6.6. Global Biochips Market, Sub-Segmentation Of Protein Chips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Arrays
• Protein Microarrays
• Peptide Arrays
• 6.7. Global Biochips Market, Sub-Segmentation Of Lab-On-Chip, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microfluidic Devices
• Biosensors
• 6.8. Global Biochips Market, Sub-Segmentation Of Tissue Arrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Tissue Arrays
• Normal Tissue Arrays
• 6.9. Global Biochips Market, Sub-Segmentation Of Cell Arrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Biochips
• Cell Signaling Arrays

7. Biochips Market Regional And Country Analysis

• 7.1. Global Biochips Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biochips Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biochips Market

• 8.1. Asia-Pacific Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biochips Market

• 9.1. China Biochips Market Overview
• 9.2. China Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biochips Market

• 10.1. India Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biochips Market

• 11.1. Japan Biochips Market Overview
• 11.2. Japan Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biochips Market

• 12.1. Australia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biochips Market

• 13.1. Indonesia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biochips Market

• 14.1. South Korea Biochips Market Overview
• 14.2. South Korea Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biochips Market

• 15.1. Western Europe Biochips Market Overview
• 15.2. Western Europe Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biochips Market

• 16.1. UK Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biochips Market

• 17.1. Germany Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biochips Market

• 18.1. France Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biochips Market

• 19.1. Italy Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biochips Market

• 20.1. Spain Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biochips Market

• 21.1. Eastern Europe Biochips Market Overview
• 21.2. Eastern Europe Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biochips Market

• 22.1. Russia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biochips Market

• 23.1. North America Biochips Market Overview
• 23.2. North America Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biochips Market

• 24.1. USA Biochips Market Overview
• 24.2. USA Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biochips Market

• 25.1. Canada Biochips Market Overview
• 25.2. Canada Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biochips Market

• 26.1. South America Biochips Market Overview
• 26.2. South America Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biochips Market

• 27.1. Brazil Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biochips Market

• 28.1. Middle East Biochips Market Overview
• 28.2. Middle East Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biochips Market

• 29.1. Africa Biochips Market Overview
• 29.2. Africa Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biochips Market Competitive Landscape And Company Profiles

• 30.1. Biochips Market Competitive Landscape
• 30.2. Biochips Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biochips Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. QIAGEN N.V.
• 31.4. Tecan Group Ltd.
• 31.5. Cepheid Inc.
• 31.6. Randox Laboratories Ltd.
• 31.7. Takara Bio Inc.
• 31.8. Oxford Nanopore Technologies plc
• 31.9. Luminex Corporation
• 31.10. Fluidigm Corporation
• 31.11. Micronit Microtechnologies B.V.
• 31.12. Sphere Fluidics Limited
• 31.13. Sengenics
• 31.14. Arrayit Corporation
• 31.15. CustomArray Inc.

32. Global Biochips Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biochips Market

34. Recent Developments In The Biochips Market

35. Biochips Market High Potential Countries, Segments and Strategies

• 35.1 Biochips Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biochips Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biochips Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer